Liquid biopsy in neuroblastoma: cfDNA analysis for sensitive follow-up monitoring and early relapse detection
Teresa Gerber, Sabine Taschner‐Mandl, Anna Buder, L Saloberger et autres
Background: In the current SIOPEN high-risk neuroblastoma (NB) study, MRD detection methods are based on bone marrow (BM) samples. When, however, relapses occur outside the BM, disease detection may fail. Due to their minimal invasive nature, peripheral blood (PB) plasma based liquid …
at (code pays fourni par la source)
0 citations
Klinische Pädiatrie